Niels Borgstein

Corporate Officer/Principal at ALKERMES PLC

Health Technology

Consumer Services

Profile

Niels Borgstein is a professional with a doctorate degree from the University of Groningen.
He is currently working as SVP-Late Stage Clinical Development at Alkermes Plc.
Prior to this, he worked as Senior Director at Stryker Biotech LLC, Principal at Pfizer Inc., Vice President & Head-Clinical Development at Ironwood Pharmaceuticals, Inc., and Vice President-Medical Research at Acceleron Pharma, Inc.

Niels Borgstein active positions

Companies	Position	Start
ALKERMES PLC	Corporate Officer/Principal	01/01/2021

All active positions of Niels Borgstein

Former positions of Niels Borgstein

Companies	Position	End
IRONWOOD PHARMACEUTICALS, INC.	Corporate Officer/Principal	-
Stryker Biotech LLC Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA.	Director/Board Member	-
PFIZER, INC.	Corporate Officer/Principal	-
ACCELERON PHARMA INC.	Corporate Officer/Principal	-

See the detail of Niels Borgstein's experience

Training of Niels Borgstein

University of Groningen

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Niels Borgstein's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
PFIZER, INC.	Health Technology
ALKERMES PLC	Health Technology
IRONWOOD PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Acceleron Pharma, Inc. Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.	Health Technology
Stryker Biotech LLC Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA.	Health Technology